Upgrade to SI Premium - Free Trial

CVS Health (CVS) Reiterated at Overweight by Cantor Fitzgerald Amid Margin Recovery

October 1, 2026 7:19 AM
Cantor Fitzgerald analyst Sarah James reiterated an Overweight rating and $110.00 price target on CVS Health (NYSE: CVS).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments